Rhode Island Confirms Second Measles Case of 2026 in Traveler from Abroad
- Health officials have confirmed Rhode Island's second measles case of 2026, involving a woman in her 20s who had traveled from outside the country to visit family in...
- The Rhode Island Department of Health (RIDOH) announced the case on April 25, 2026, stating that the individual was treated at Brown University Health Urgent Care in Middletown...
- This case is unrelated to the state's first measles case of 2026, which was identified on April 18.
Health officials have confirmed Rhode Island’s second measles case of 2026, involving a woman in her 20s who had traveled from outside the country to visit family in the state.
The Rhode Island Department of Health (RIDOH) announced the case on April 25, 2026, stating that the individual was treated at Brown University Health Urgent Care in Middletown on April 24 and tested positive for measles at the Rhode Island State Health Laboratories. The patient did not require hospitalization.
This case is unrelated to the state’s first measles case of 2026, which was identified on April 18. Health officials emphasized that the two cases are not linked and that the recent patient did not report visiting any other locations since arriving in Rhode Island.
RIDOH is conducting outreach to individuals who may have been exposed to the virus at the urgent care center in Middletown on April 24. Anyone who believes they may have been exposed and begins to develop symptoms of measles is advised to contact their healthcare provider before visiting a medical facility to avoid potential transmission.
According to RIDOH, individuals who have previously had measles or received two doses of the measles, mumps, and rubella (MMR) vaccine are unlikely to contract the disease even if exposed. The department highlighted that approximately 97% of Rhode Island kindergarteners have completed the MMR vaccine series, contributing to a low risk of significant spread.
Director of Health Jerry Larkin, MD, stated that the high vaccination rate in the state reduces the likelihood of widespread transmission but stressed that community protection depends on eligible individuals receiving the vaccine. He encouraged parents or guardians of unvaccinated children over one year old to consult their healthcare provider about vaccination.
RIDOH noted that the first dose of the MMR vaccine is typically administered between 12 and 15 months of age, with a second dose given between 4 and 6 years old. The department also advised that anyone planning international travel should be fully vaccinated beforehand, and that infants aged 6 to 11 months should receive one dose of the MMR vaccine prior to travel, followed by two additional doses after their first birthday according to the standard schedule.
For families facing insurance or access challenges, RIDOH can provide the MMR vaccine at no cost. The department continues to monitor the situation and coordinate with healthcare providers to ensure appropriate follow-up and public guidance.
